TNF and diabetes mellitus: In addition to the anti-inflammatory effect of anti-TNF-α therapy and the consequential improvement of joint function, they may indirectly lead to increased levels of physical activity, which will subsequently decrease the incidence of other cardiovascular risk factors, such as diabetes mellitus and hypertension [114].